Results of combination treatment using docetaxel in an adjuvant chemotherapy regimen for resectable breast cancer
Breast cancer (BC) dominates in the structure of cancer morbidity and mortality in women worldwide. Despite the advances made in the treatment of this pathology, there is still a variety of unsolved problems, including those associated with disease progression after radical sur- gical interventions....
Saved in:
Main Authors: | L. V. Bolotina (Author), T. I. Deshkina (Author) |
---|---|
Format: | Book |
Published: |
ABV-press,
2014-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
PHARMACOECONOMIC ANALYSIS OF DOCETAXEL IN THE ADJUVANT THERAPY OF BREAST CANCER
by: R. I. Yagudina, et al.
Published: (2015) -
Intensified dose-dense neoadjuvant chemotherapy using paclitaxel-gemcitabine and docetaxel-doxorubicin combinations for locally advanced breast cancer
by: I. V. Frai, et al.
Published: (2014) -
Evolution of Adjuvant Chemotherapy and Efficacy of Commonly Used Regimens in Colorectal Cancer
by: S.M. Adiga, et al.
Published: (2012) -
Efficacy and safety of goserelin combined with adjuvant chemotherapy in premenopausal women with breast cancer
by: Yang Wang, et al.
Published: (2015) -
Neo-adjuvant chemotherapy in stage IIIC potentially resectable epithelial ovarian cancer
by: Ioannis A. Voutsadakis
Published: (2017)